Global prevalence of hepatitis B in 2022: a modelling study
Telemedicine Consult - Dr. Gish
Schedule Telemedicine Consult with Dr. Gish

Global prevalence of hepatitis B in 2022: a modelling study

Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

The 2016 World Health Assembly endorsed the elimination of hepatitis B virus (HBV) infection as a public health threat by 2030; existing therapies and prophylaxis measures make such elimination feasible, even in the absence of a virological cure. We aimed to estimate the national, regional, and global prevalence of HBV in the general population and among children aged 5 years and younger, as well as the rates of diagnosis, treatment, prophylaxis, and the future burden globally. 

Download Article


Metadata